Your browser doesn't support javascript.
loading
Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.
Frommeyer, Gerrit; Sterneberg, Magdalena; Dechering, Dirk G; Kaese, Sven; Bögeholz, Nils; Pott, Christian; Fehr, Michael; Bogossian, Harilaos; Milberg, Peter; Eckardt, Lars.
Afiliação
  • Frommeyer G; Division of Clinical and Experimental Electrophysiology, Department of Cardiology and Angiology, University Hospital of Münster, Münster, Germany.
  • Sterneberg M; Division of Clinical and Experimental Electrophysiology, Department of Cardiology and Angiology, University Hospital of Münster, Münster, Germany.
  • Dechering DG; Division of Clinical and Experimental Electrophysiology, Department of Cardiology and Angiology, University Hospital of Münster, Münster, Germany.
  • Kaese S; Division of Clinical and Experimental Electrophysiology, Department of Cardiology and Angiology, University Hospital of Münster, Münster, Germany.
  • Bögeholz N; Division of Clinical and Experimental Electrophysiology, Department of Cardiology and Angiology, University Hospital of Münster, Münster, Germany.
  • Pott C; Division of Clinical and Experimental Electrophysiology, Department of Cardiology and Angiology, University Hospital of Münster, Münster, Germany.
  • Fehr M; Clinic of Exotic Pets, Reptiles, Exotic and Feral Birds, University of Hanover, Hanover, Germany.
  • Bogossian H; Märkische Kliniken GmbH, Department of Cardiology and Angiology, Klinikum Lüdenscheid, University of Witten-Herdecke, Witten, Germany.
  • Milberg P; Division of Clinical and Experimental Electrophysiology, Department of Cardiology and Angiology, University Hospital of Münster, Münster, Germany.
  • Eckardt L; Division of Clinical and Experimental Electrophysiology, Department of Cardiology and Angiology, University Hospital of Münster, Münster, Germany.
Cardiovasc Ther ; 35(2)2017 Apr.
Article em En | MEDLINE | ID: mdl-28039911

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Frequência Cardíaca / Antagonistas dos Receptores Histamínicos H1 / Antazolina / Antiarrítmicos Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Cardiovasc Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Frequência Cardíaca / Antagonistas dos Receptores Histamínicos H1 / Antazolina / Antiarrítmicos Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Cardiovasc Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha